Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Forchhammer

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Acta Dermato-Venereologica|March 30, 2023
Diagnosis of Basal Cell Carcinoma with Ex-vivo Confocal Laser Scanning Microscopy in a Real-life SettingStephan Forchhammer, Sonja Grunewald, Matthias Möhrle, et al.
Pigment Cell & Melanoma Research|July 20, 2023
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stageValentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 27, 2025
BAPoma, a rare nevus, as the key to a diagnosis of BAP1-associated tumor predisposition syndromeLara Racz, Sandra Pasternack-Ziach, Isabel Spier, et al.
Acta Dermato-Venereologica|September 7, 2021
Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma ProtuberansMaximilian Gassenmaier, Erik Weber, Ulrike Leiter, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of <i>BRAF</i> V600 Mutations in Melanoma Tissue SamplesDaniela Lenders, Irina Bonzheim, Matthias Hahn, et al.
Molecular Oncology|May 27, 2025
The subcellular distribution of phosphorylated Y-box-binding protein-1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological featuresKonstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, et al.
Cancers|August 7, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin MelanomasMaximilian Gassenmaier, Matthias Hahn, Gisela Metzler, et al.
Frontiers in Oncology|September 1, 2023
Case Report: Paraneoplastic psoriasis in thymic carcinomaLucas Mix, Manuel Knoll, Max-Felix Häring, et al.
The Journal of Pathology. Clinical Research|September 4, 2025
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesisDominik Nann, Tim-Colin Schade, Mathis Overkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2025
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsyTeresa Amaral, Eftychia Chatziioannou, Alica Nuebling, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Acta Dermato-Venereologica|March 30, 2023
Diagnosis of Basal Cell Carcinoma with Ex-vivo Confocal Laser Scanning Microscopy in a Real-life SettingStephan Forchhammer, Sonja Grunewald, Matthias Möhrle, et al.
Pigment Cell & Melanoma Research|July 20, 2023
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stageValentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 27, 2025
BAPoma, a rare nevus, as the key to a diagnosis of BAP1-associated tumor predisposition syndromeLara Racz, Sandra Pasternack-Ziach, Isabel Spier, et al.
Acta Dermato-Venereologica|September 7, 2021
Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma ProtuberansMaximilian Gassenmaier, Erik Weber, Ulrike Leiter, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of <i>BRAF</i> V600 Mutations in Melanoma Tissue SamplesDaniela Lenders, Irina Bonzheim, Matthias Hahn, et al.
Molecular Oncology|May 27, 2025
The subcellular distribution of phosphorylated Y-box-binding protein-1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological featuresKonstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, et al.
Cancers|August 7, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin MelanomasMaximilian Gassenmaier, Matthias Hahn, Gisela Metzler, et al.
Frontiers in Oncology|September 1, 2023
Case Report: Paraneoplastic psoriasis in thymic carcinomaLucas Mix, Manuel Knoll, Max-Felix Häring, et al.
The Journal of Pathology. Clinical Research|September 4, 2025
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesisDominik Nann, Tim-Colin Schade, Mathis Overkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2025
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsyTeresa Amaral, Eftychia Chatziioannou, Alica Nuebling, et al.
Pageof 7